ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

HEMO Hemogenyx Pharmaceuticals Plc

1.567
0.002 (0.13%)
02 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Hemogenyx Pharmaceuticals Plc LSE:HEMO London Ordinary Share GB00BYX3WZ24 ORD GBP0.01
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.002 0.13% 1.567 1.536 1.598 1.55 1.538 1.55 4,833,427 16:35:27
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Finance Services 0 -3.98M -0.0035 -4.40 17.59M
Hemogenyx Pharmaceuticals Plc is listed in the Finance Services sector of the London Stock Exchange with ticker HEMO. The last closing price for Hemogenyx Pharmaceuticals was 1.57p. Over the last year, Hemogenyx Pharmaceuticals shares have traded in a share price range of 1.125p to 6.30p.

Hemogenyx Pharmaceuticals currently has 1,141,999,321 shares in issue. The market capitalisation of Hemogenyx Pharmaceuticals is £17.59 million. Hemogenyx Pharmaceuticals has a price to earnings ratio (PE ratio) of -4.40.

Hemogenyx Pharmaceuticals Share Discussion Threads

Showing 13226 to 13249 of 13425 messages
Chat Pages: 537  536  535  534  533  532  531  530  529  528  527  526  Older
DateSubjectAuthorDiscuss
01/3/2024
08:30
Orchestralis 29 Feb '24 - 21:34 - 8802 of 8804

I'm not sure what people expect. This is an early stage pharma with no revenue currently. They have to raise money through the markets to fund research and development. Why is that so surprising/disappointing for people.

apotheki
29/2/2024
23:53
Dont tell the FDA it's a fraud ffs
saint in exile
29/2/2024
21:34
I'm not sure what people expect. This is an early stage pharma with no revenue currently. They have to raise money through the markets to fund research and development. Why is that so surprising/disappointing for people.
orchestralis
29/2/2024
18:06
Over on the lse forums it is like something I never seen before in how excited the posters was about BOIL and HEMO before these dreaded placing come along. I wouldn't be surprised if at least one has not hung themselves. It must be so depressing all this disappointment on top of disappointment for them. It's bad enough for me loosing 40k that is hopefully going to recover some of it soon.
luckyabbeygale
29/2/2024
17:34
Vlad is a deceiver and Fraudster, He has been doing this to the shareholders for many many years. Artificially pumping price with Lies and than raising funds via placing to pay his and his crook team huge salaries.
trader4ever
29/2/2024
14:15
Absolutely spot on Paul, time and time again this happens to the unwary investor and it's scandalous how easy it is to get away with it. Some of the financial press are complicit in this - on a regular basis. Perhaps they are plain lazy and don't do any research before they write a glowing article for a company promote - or perhaps they are just interested in any old story and just haven't got a conscience. Perhaps they don't have any financial experience at all and are just as unwary as some PIs. My tactic now is that if there is a sudden concerted effort by a co. to ramp its share price and its balance sheet is low on cash then if I'm holding the share I sell into the price spike - more often than not there's a fund raise coming soon.

Fundraises Generally

A pattern seems to be emerging, where speculative companies run out of cash, then they pump the share price with upbeat-sounding RNSs. Shortly afterwards they announce a discounted placing into any subsequent share price rise. Private investors speculating on these shares, buying the price rises, seem to be lambs to the slaughter.

It doesn't seem right to me that shares are still trading, when the company is secretly offering discounted shares to larger investors in placings. It's often obvious from the share price that news has leaked. We really do need the rules changed (and/or enforced), so that shares are suspended when any company decides to do a fundraise. Also we need quicker, cheaper mechanisms for companies to raise cash.

In the meantime, there's a simple way to avoid being clobbered by a discounted placing - don't buy or hold any share where the company doesn't have a cash runway of well over 12 months. Ideally investments should be companies which are profitable and cash generative, hence won't ever need to raise more cash just to keep the lights on.

Jam tomorrow/ blue sky shares are a graveyard for optimistic investors, avoiding these things has been the biggest boost for my personal portfolio returns. That said, the odd one multibags, which is what excites people.

apotheki
29/2/2024
14:15
Vlad is a deceiver, He has been doing this to shareholders for many many years.
trader4ever
29/2/2024
11:34
Jibba, I`m with you on that, in the next month or two
I can see 1.5p, very little confidence left in this company!

trek3
29/2/2024
11:27
This will bounce again on the next news.
orchestralis
29/2/2024
11:13
Not at all Jibba Jabber as I for one really appreciate your honest approach which is most refreshing I must say. On the other hand I am now buying again sub the placing price so sub 2p. Anyways each to their own I guess.
apotheki
29/2/2024
11:07
Keeping powder dry, i know this comment won't be welcome by holders but i see a 1.5p ish buying opp.
jibba jabber
29/2/2024
10:56
Sorry for the long term holders. Vlad cannot be trusted he has shown time and time again.
trying2trade
29/2/2024
10:31
That was my thought too.
countbasie1
29/2/2024
10:31
Jayrh You are confused. I didn't ask that question.
countbasie1
29/2/2024
10:16
You asked what the money would be used for and it tells you in the rns. Clinical trials money is another story
jayrh
29/2/2024
09:50
Perhaps it is just a bit too early now but not for phases 2 & 3
apotheki
29/2/2024
09:48
Or alternatively a major industry players joins the party with a gift of mega bucks?
apotheki
29/2/2024
09:46
smart money to be made ! The share price will fall below the placing price !

do not override Dr Sandlers awarded share option are being Primed to be

added to the shares in issue in the New Financial year !

dreamtwister
29/2/2024
09:00
How do you think.More Placings and on it goes
saint in exile
29/2/2024
08:52
Jayrh That's what it says. Then how do they pay for clinical trials which are very expensive?
countbasie1
29/2/2024
08:47
Read the rns. This money will be used to progress car t to clinical trials
jayrh
29/2/2024
08:44
Beeks I didnt buy that much and was at 2.4p so not that far away.Wonder how long this money will last before the next placing.Guess that's the thing,these clinical trials go on for years with no revenue coming in apart from CRs.
saint in exile
29/2/2024
08:40
Tempted for some Hemo, but worried it will take to long to clear.
If I get some spread bet funds from Oriole rising I will get back into Hemo.

I have 55 grand of normal share money in Oriole, and 30 grand of spread bet funds into Oriole and different shares.

luckyabbeygale
29/2/2024
08:37
Ok, change the record now fella, no point crying over spilt milk.It's gone now, some will see today as an opportunity to buy at the placement price... others will see 166m shares that will be sold into any rise so likely to see a below placement opportunity as those on T+ have no option but to sell.
roughandtumbleone
Chat Pages: 537  536  535  534  533  532  531  530  529  528  527  526  Older

Your Recent History

Delayed Upgrade Clock